November 17, 2025

‘Patent Dance’ Delays Biosimilars Despite FDA Shift

The FDA moves to speed biosimilar approvals, but rising patent barriers may still delay lower-cost alternatives.

Conexiant

November 15, 2025

AI Models Predict CNS Tumors From Spinal Fluid

At AMP 2025, a South Korean research team outlined a multimodal approach that integrates CSF, DNA, and MRI data to enable early, noninvasive tumor classification.

Conexiant

November 14, 2025

New ddPCR Test Detects Lyme Disease More Accurately

The droplet digital PCR assays, developed at Dartmouth, could improve diagnosis of Lyme disease.

Conexiant

November 13, 2025

Allergies May Increase Surgical Risk

Researchers show that patients with allergies face higher postoperative risks.

Conexiant

November 12, 2025

CDER Taps FDA Veteran as Director 

The HHS and FDA have appointed longtime oncology innovator Richard Pazdur, MD, as director of the Center for Drug Evaluation and Research.

Conexiant

November 10, 2025

Gastric microbiome shifts track H pylori virulence

Pathogenic bacterial genotypes correlate with distinct microbial communities; overall α-diversity is unchanged, but virulent strains show greater diversity within subgroups as atrophy progresses

Conexiant

November 10, 2025

Can Mucoactive Therapy Change Bronchiectasis Outcomes?

Researchers examine mucoactive therapy effectiveness in bronchiectasis management.

Conexiant

November 07, 2025

At What Age Do We Have the Strongest Immunity?

A multi-omic study defines the immune system’s lifelong trajectory

The Pathologist

November 07, 2025

AAOS Revises Dental Protocol for Joint Arthroplasty

Orthopedic and dental experts revised infection prevention recommendations.

Conexiant